Inlyta

Inlyta

Basic Prescribing Info
Contents
Axitinib
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EK01 - axitinib ; Belongs to the class of vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in